logo-loader
NASDAQ:GERN

Geron

Receive alerts
Market:
NASDAQ
Market Cap:
$664.18 m
Price
2.14 USD
Change
-1.83%
52 weeks high
2.40
52 weeks low
0.75

In brief

Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The Company operates in one segment, the discovery and development of therapeutic products for oncology.